Mertz H, Walsh J H, Sytnik B, Mayer E A
Department of Medicine, UCLA 90073, USA.
Neurogastroenterol Motil. 1995 Sep;7(3):175-85. doi: 10.1111/j.1365-2982.1995.tb00223.x.
Somatostatin or its analogue octreotide (OCT) has previously been shown to modulate gastric emptying, intestinal motor activity and visceral sensation. In the current study we sought to determine the effect of a single dose of OCT (1.25 micrograms kg-1 s.c.), which has previously been shown to have both motor and sensory effects, on proximal gastric compliance and on conscious perception of gastric distention. Gastric distention was performed in 13 healthy male volunteers, by either slow ramp distention (60 ml min-1) or by intermittent pressure steps (phasic distention; 4-20 mmHg) using an electronic distention device. Compliance curves (pressure-volume relationship), and thresholds for innocuous (fullness) and noxious sensations (discomfort, pain) were determined following vehicle or OCT injection. OCT consistently and significantly reduced the rate of the gastric accommodation reflex by 50%, resulting in a reduced compliance at distention pressures greater than 10 mmHg during phasic distention. In contrast, no effect was observed on the compliance curve obtained during ramp distention. OCT selectively increased the threshold for fullness during both ramp and phasic distention. During phasic distention, OCT decreased the volume thresholds for noxious (pain) sensations experienced at volumes greater than 300 ml, without affecting the corresponding pressure threshold. These findings suggest that at low distension volumes, OCT in the dosage used has a direct inhibitory effect on afferents mediating innocuous gastric sensations. The hyperalgesic effect observed during phasic distention may be secondary to OCT's inhibitory effect on the gastric accommodation reflex.
生长抑素或其类似物奥曲肽(OCT)此前已被证明可调节胃排空、肠道运动活性和内脏感觉。在本研究中,我们试图确定单剂量奥曲肽(1.25微克/千克皮下注射)对胃近端顺应性和胃扩张的清醒感知的影响,该剂量的奥曲肽此前已被证明具有运动和感觉效应。使用电子扩张装置,对13名健康男性志愿者进行胃扩张,采用缓慢斜坡扩张(60毫升/分钟)或间歇性压力阶跃(相位扩张;4 - 20毫米汞柱)。在注射载体或奥曲肽后,测定顺应性曲线(压力 - 容积关系)以及无害(饱腹感)和有害感觉(不适、疼痛)的阈值。奥曲肽持续且显著地使胃容受性反射速率降低50%,导致在相位扩张期间,扩张压力大于10毫米汞柱时顺应性降低。相比之下,在斜坡扩张期间获得的顺应性曲线未观察到影响。奥曲肽在斜坡扩张和相位扩张期间均选择性地提高了饱腹感阈值。在相位扩张期间,奥曲肽降低了在大于300毫升容积时所经历的有害(疼痛)感觉的容积阈值,而不影响相应的压力阈值。这些发现表明,在低扩张容积时,所用剂量的奥曲肽对介导无害胃感觉的传入神经有直接抑制作用。在相位扩张期间观察到的痛觉过敏效应可能继发于奥曲肽对胃容受性反射的抑制作用。